Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation
European Journal of Pharmacology · 2024
DOI: 10.1016/j.ejphar.2024.176352 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Ying Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Med-icine, Changsha, 410208, Hunan, China; Shenzhe…. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Curcumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Changsha Science and Technology Project, Science and Technology Program of Hunan Province.
Abstract (Originalsprache)
BACKGROUND: Curcumin nicotinate (Curtn), derived from curcumin and niacin, reduces serum LDL-C levels, partly due to its influence on PCSK9. This study investigates IDOL's role in Curtn's lipid-lowering effects. OBJECTIVE: To elucidate Curtn's regulation of the IDOL/LDLR pathway and potential molecular mechanisms in hepatocytes. METHODS: Differential metabolites in Curtn-treated HepG2 cells were identified via LC-MS. Molecular docking assessed Curtn's affinity with IDOL. Cholesterol content and LDLR expression effects were studied in high-fat diet Wistar rats. In vitro evaluations determined Curtn's influence on IDOL overexpression's LDL-C uptake and LDLR expression in hepatocytes. RESULTS: Lipids were the main differential metabolites in Curtn-treated HepG2 cells. Docking showed Curtn's higher affinity to IDOL's FERM domain compared to curcumin, suggesting potential competitive inhibition of IDOL's binding to LDLR. Curtn decreased liver cholesterol in Wistar rats and elevated LDLR expression. During in vitro experiments, Curtn significantly enhanced the effects of IDOL overexpression in HepG2 cells, leading to increased LDL-C uptake and elevated expression of LDL receptors. CONCLUSION: Curtn modulates the IDOL/LDLR pathway, enhancing LDL cholesterol uptake in hepatocytes. Combined with its PCSK9 influence, Curtn emerges as a potential hyperlipidemia therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, Hunan University of Chinese Med-icine, Changsha, 410208, Hunan, China; Shenzhen Samii Medical Center, Shenzhen, 518118, Guangdong, China. Electronic…
- Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: liufangyuan1126@163.com.
- Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: 765614982@qq.com.
- Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: 1591998771@qq.com.
- Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: zhumeiqi0207@163.com.
- Department of Biochemistry & Molecular Biology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: wwjj006@126.com.
Förderung
- Natural Science Foundation of Hunan Province
- Changsha Science and Technology Project
- Science and Technology Program of Hunan Province
Zitieren
APA
Huang, Y., Liu, F. Y., Yang, J. T., Zhao, Q., Zhu, M. Q., Wang, J., Long, S. Y., Tuo, Q. H., Zhang, C. P., Lin, L. M., & Liao, D. F. (2024). Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2024.176352
Vancouver
Huang Y, Liu FY, Yang JT, Zhao Q, Zhu MQ, Wang J, et al. Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2024.176352
BibTeX
@article{Huang2024,
author = {Huang, Ying and Liu, Fang-Yuan and Yang, Jia-Tao and Zhao, Qian and Zhu, Mei-Qi and Wang, Jing and Long, Shi-Yin and Tuo, Qin-Hui and Zhang, Cai-Ping and Lin, Li-Mei and Liao, Duan-Fang},
title = {Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation},
journal = {European Journal of Pharmacology},
year = {2024},
doi = {10.1016/j.ejphar.2024.176352}
}
EUVIMED